Study of ONO-4538 in Gastric Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 268
Summary
- Conditions
- Gastric Cancer
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02746796
- Collaborators
- Not Provided
- Investigators
- Study Director: Mitsunobu Tanimoto Ono Pharmaceutical Co. Ltd
Get Well Soon